CRIS Current Research Information System

SANTUCCI, MARIA ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.371
AS - Asia 2.858
EU - Europa 2.307
AF - Africa 171
SA - Sud America 116
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.333
VN - Vietnam 846
SG - Singapore 793
CN - Cina 705
GB - Regno Unito 612
DE - Germania 320
SE - Svezia 290
IT - Italia 225
UA - Ucraina 193
FR - Francia 142
HK - Hong Kong 140
RU - Federazione Russa 134
IN - India 120
IE - Irlanda 92
NL - Olanda 86
BR - Brasile 80
JP - Giappone 58
TG - Togo 54
ZA - Sudafrica 54
EE - Estonia 42
FI - Finlandia 37
KR - Corea 33
CH - Svizzera 31
JO - Giordania 27
TH - Thailandia 22
BG - Bulgaria 20
CA - Canada 20
SC - Seychelles 19
BE - Belgio 17
CI - Costa d'Avorio 16
NG - Nigeria 15
AR - Argentina 13
IR - Iran 13
MX - Messico 13
BD - Bangladesh 12
GR - Grecia 12
ID - Indonesia 12
IQ - Iraq 11
PH - Filippine 10
PL - Polonia 10
RO - Romania 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
TW - Taiwan 8
TR - Turchia 7
UZ - Uzbekistan 7
AU - Australia 6
EC - Ecuador 6
HR - Croazia 6
LT - Lituania 6
PK - Pakistan 6
ES - Italia 5
NP - Nepal 5
CL - Cile 4
PE - Perù 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
DZ - Algeria 3
MA - Marocco 3
CO - Colombia 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
PT - Portogallo 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
ET - Etiopia 1
GI - Gibilterra 1
GM - Gambi 1
HU - Ungheria 1
KW - Kuwait 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 8.831
Salva come PNG Salva come JPEG
Città #
Singapore 560
Southend 514
Ashburn 361
Chandler 317
Fairfield 315
San Jose 197
Wilmington 173
Seattle 164
Dong Ket 160
Woodbridge 152
Houston 141
Ho Chi Minh City 140
Jacksonville 137
Hong Kong 131
Hanoi 127
Ann Arbor 126
Princeton 111
Beijing 107
Cambridge 107
Dublin 91
Hefei 88
Boardman 71
Santa Clara 68
Nanjing 60
Lomé 54
Westminster 53
Padova 52
Tokyo 47
Lauterbourg 44
New York 43
Berlin 41
Los Angeles 40
Helsinki 36
Bologna 32
Frankfurt am Main 32
Bern 28
Jinan 28
Amman 26
Seoul 26
Buffalo 25
Shenyang 24
Da Nang 23
Milan 21
Changsha 20
Medford 20
Mülheim 20
Sofia 20
Falkenstein 19
Falls Church 19
Hebei 19
San Diego 19
Saint Petersburg 18
Abidjan 16
Brussels 16
Abeokuta 15
Haiphong 15
Nanchang 15
Redmond 15
Tianjin 15
Verona 15
Guangzhou 13
Taizhou 13
Des Moines 11
Hangzhou 11
Phoenix 11
Bengaluru 10
London 10
Redondo Beach 10
Shanghai 10
Turin 10
Bangkok 9
Mahé 9
Toronto 9
Zhengzhou 9
Dallas 8
Dearborn 8
Jakarta 8
Kuban 8
Norwalk 8
São Paulo 8
Xi'an 8
Bühl 7
Jiaxing 7
Johannesburg 7
Munich 7
Ningbo 7
Rome 7
Baghdad 6
Bremen 6
Florence 6
Harbin 6
Long Xuyen 6
Nuremberg 6
Portsmouth 6
The Dalles 6
Washington 6
Andover 5
Biên Hòa 5
Düsseldorf 5
Kunming 5
Totale 5.706
Salva come PNG Salva come JPEG
Nome #
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib 272
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia 265
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 262
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. 241
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 226
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 226
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 219
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia 219
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia 200
CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 198
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia 195
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 190
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 188
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 186
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 185
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. 184
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 181
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. 177
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 176
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 172
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 172
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 170
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene 169
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 167
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 166
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 165
P53 and beta catenin cross-talk in the medulloblastoma cell line radiosensitivity 161
FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia 160
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 159
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 156
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 155
GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) 154
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia 152
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein 152
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. 151
Tyrosine kinase inhibotr STI571 (Imatinib) cooperates with wild type p53 on k562 cell line to enhance its pro-apoptotic effets 150
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 145
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia. 144
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 141
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells 141
P210 BCR-ABL TYROSINE KINASE INHIBITS APOPTOTIC CELL DEATH THROUGH MULTIPLE PATHWAYS PREVENTING EARLY MITOCHONDRIAL ACTIVATION 137
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) 137
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE 136
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias 136
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 136
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 134
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia 131
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 126
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 124
Idetification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. 117
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction. 98
La tirosin-cinasi del prodotto p210 di bcr-abl sopprime l'apoptosi mitocondrio dipendente 84
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 76
The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics 71
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3 sigma case. 2
Totale 8.937
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021383 0 0 0 0 0 0 0 0 0 37 56 290
2021/20221.118 190 28 86 81 87 58 27 58 31 72 210 190
2022/20231.189 133 205 71 145 82 107 25 51 189 32 85 64
2023/2024304 18 49 16 49 19 79 22 14 8 13 8 9
2024/20251.016 19 149 96 73 181 61 53 62 10 139 15 158
2025/20262.378 217 214 193 164 372 168 214 123 534 179 0 0
Totale 8.937